Episode 1

The Rise of AI in Pharma & Biotech with Bill Wallace

Welcome to the first episode of the Biotech Bytes podcast! 

Today, we have an insightful conversation with Bill Wallace from Intercept Pharmaceuticals, exploring the transformative role of AI in the pharmaceutical and biotech industries.

Bill talks about how working together and keeping data safe are key in these industries. He dives into the specific challenges the industry faces, like making sure smaller companies can access data and adapting to the new things AI can do.

We also touch on the critical role of AI in patient safety and drug development, while addressing the challenges of data protection.

As we navigate through this conversation, it becomes evident that the integration of AI in pharma and biotech is a delicate balancing act. It requires an approach that harmonizes innovation with prudence.

Join us to discover how AI is making a significant impact in the pharma and biotech industries. This episode is going to give you a great look into how AI is really shaking things up in our industry. Tune in to learn all about it!

Specifically, this episode highlights the following themes:

  • The integral role of AI in advancing pharmaceutical research and patient care
  • Confronting cybersecurity challenges in an AI-enhanced pharmaceutical industry
  • Navigating the financial and strategic landscape for AI adoption in varying company sizes

Links from this episode:

==== Time Stamps ====

00:00 – Introduction
00:48 – About Bill Wallace
03:24 – Early applications of AI in pharma
05:26 – Considerations for data security and AI bias
07:40 – Anecdote about data privacy and ChatGPT
09:00 – Challenges of integrating AI in corporate environments
11:29 – Building data organizations in smaller companies
13:28 – Collaborative opportunities in data sharing and AI
16:54 – Managing clinical trial data in cloud environments
18:17 – AI use in clinical settings and pharmacovigilance
24:21 – The emergence of AI security
31:54 – The future of AI in pharma and biotech
35:40 – Connect with Steven Swan and Bill Wallace

Go to Top